LU81284A1 - Nouveaux derives de 4-amino-2-piperidino-quinazoline,leur procede de production et medicament les contenant - Google Patents
Nouveaux derives de 4-amino-2-piperidino-quinazoline,leur procede de production et medicament les contenant Download PDFInfo
- Publication number
- LU81284A1 LU81284A1 LU81284A LU81284A LU81284A1 LU 81284 A1 LU81284 A1 LU 81284A1 LU 81284 A LU81284 A LU 81284A LU 81284 A LU81284 A LU 81284A LU 81284 A1 LU81284 A1 LU 81284A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- group
- formula
- compound
- preparation
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2035178 | 1978-05-18 | ||
| GB2035178 | 1978-05-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU81284A1 true LU81284A1 (fr) | 1980-12-16 |
Family
ID=10144517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU81284A LU81284A1 (fr) | 1978-05-18 | 1979-05-17 | Nouveaux derives de 4-amino-2-piperidino-quinazoline,leur procede de production et medicament les contenant |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US4243666A (hu) |
| JP (1) | JPS554370A (hu) |
| AR (2) | AR223487A1 (hu) |
| AT (1) | ATA363379A (hu) |
| AU (1) | AU512947B2 (hu) |
| BE (1) | BE876297A (hu) |
| CA (1) | CA1240325A (hu) |
| CH (1) | CH643553A5 (hu) |
| CS (1) | CS214796B2 (hu) |
| DD (1) | DD143613A5 (hu) |
| DE (1) | DE2919800A1 (hu) |
| DK (1) | DK159079A (hu) |
| ES (2) | ES480671A1 (hu) |
| FI (1) | FI64589C (hu) |
| FR (1) | FR2434162A1 (hu) |
| GR (1) | GR72824B (hu) |
| HU (1) | HU182562B (hu) |
| IL (1) | IL57297A (hu) |
| IN (1) | IN153045B (hu) |
| IT (1) | IT1114222B (hu) |
| LU (1) | LU81284A1 (hu) |
| NL (1) | NL172157C (hu) |
| NO (1) | NO791648L (hu) |
| NZ (1) | NZ190465A (hu) |
| PH (1) | PH14802A (hu) |
| PL (2) | PL120651B1 (hu) |
| PT (1) | PT69622A (hu) |
| SE (1) | SE439306B (hu) |
| YU (2) | YU115279A (hu) |
| ZA (1) | ZA792390B (hu) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4607034A (en) * | 1979-10-29 | 1986-08-19 | Mitsubishi Yuka Pharmaceutical Co., Ltd. | Quinazoline derivatives and pharmaceutical composition thereof |
| JPS5962766U (ja) * | 1982-06-30 | 1984-04-25 | 守田 智 | 小動物用給水器 |
| GB8414518D0 (en) * | 1984-06-07 | 1984-07-11 | Pfizer Ltd | Therapeutic agents |
| US5801195A (en) * | 1994-12-30 | 1998-09-01 | Celgene Corporation | Immunotherapeutic aryl amides |
| US6248888B1 (en) | 1997-11-14 | 2001-06-19 | Teva Pharmaceutical Industries Ltd. | Process for the preparation of terazosin hydrochloride dihydrate |
| CA2434934A1 (en) * | 2001-01-18 | 2002-07-25 | Takeda Chemical Industries, Ltd. | Process for preparation of benzylpiperidine compounds |
| US6746460B2 (en) * | 2002-08-07 | 2004-06-08 | Satiety, Inc. | Intra-gastric fastening devices |
| CA2543710A1 (en) * | 2003-11-03 | 2005-05-12 | Warner-Lambert Company Llc | Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders |
| TW200831497A (en) * | 2006-10-12 | 2008-08-01 | Epix Delaware Inc | Carboxamide compounds and their use |
| US8642758B2 (en) * | 2007-04-04 | 2014-02-04 | Cipla Limited | Process for preparation of erlotinib and its pharmaceutically acceptable salts |
| US8569282B2 (en) | 2007-12-11 | 2013-10-29 | Cytopathfinder, Inc. | Carboxamide compounds and their use |
| WO2010054968A1 (en) * | 2008-11-14 | 2010-05-20 | F. Hoffmann-La Roche Ag | Quinazoline derivatives as nk3 receptor antagonists |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1156973A (en) * | 1965-07-06 | 1969-07-02 | Quinazoline Derivatives | |
| US3511836A (en) * | 1967-12-13 | 1970-05-12 | Pfizer & Co C | 2,4,6,7-tetra substituted quinazolines |
| FR2321890A1 (fr) * | 1975-08-26 | 1977-03-25 | Synthelabo | Nouveaux derives de la quinazoline, leurs sels, leur preparation et les medicaments qui en renferment |
| DK140695C (da) * | 1976-05-07 | 1980-05-12 | Synthelabo | Analogifremgangsmaade til fremstilling af 2,4-diamino-6,7-dimethoxyquinazolinderivater eller syreadditionssalte heraf |
-
1979
- 1979-04-18 DK DK159079A patent/DK159079A/da not_active IP Right Cessation
- 1979-05-14 US US06/038,509 patent/US4243666A/en not_active Expired - Lifetime
- 1979-05-16 DE DE19792919800 patent/DE2919800A1/de not_active Ceased
- 1979-05-16 IN IN337/DEL/79A patent/IN153045B/en unknown
- 1979-05-16 CS CS793372A patent/CS214796B2/cs unknown
- 1979-05-16 PL PL1979215626A patent/PL120651B1/pl unknown
- 1979-05-16 PH PH22500A patent/PH14802A/en unknown
- 1979-05-16 AR AR276536A patent/AR223487A1/es active
- 1979-05-16 AT AT0363379A patent/ATA363379A/de not_active IP Right Cessation
- 1979-05-16 PL PL1979223844A patent/PL121158B1/pl unknown
- 1979-05-16 IL IL57297A patent/IL57297A/xx unknown
- 1979-05-16 BE BE0/195197A patent/BE876297A/xx unknown
- 1979-05-16 NO NO791648A patent/NO791648L/no unknown
- 1979-05-16 NL NLAANVRAGE7903853,A patent/NL172157C/xx not_active IP Right Cessation
- 1979-05-16 FI FI791562A patent/FI64589C/fi not_active IP Right Cessation
- 1979-05-16 GR GR59104A patent/GR72824B/el unknown
- 1979-05-16 YU YU01152/79A patent/YU115279A/xx unknown
- 1979-05-16 AU AU47101/79A patent/AU512947B2/en not_active Ceased
- 1979-05-16 IT IT22720/79A patent/IT1114222B/it active
- 1979-05-16 NZ NZ190465A patent/NZ190465A/xx unknown
- 1979-05-17 ZA ZA792390A patent/ZA792390B/xx unknown
- 1979-05-17 CH CH459879A patent/CH643553A5/de not_active IP Right Cessation
- 1979-05-17 LU LU81284A patent/LU81284A1/fr unknown
- 1979-05-17 ES ES480671A patent/ES480671A1/es not_active Expired
- 1979-05-17 HU HU79PI678A patent/HU182562B/hu unknown
- 1979-05-17 PT PT69622A patent/PT69622A/pt unknown
- 1979-05-17 SE SE7904358A patent/SE439306B/sv not_active IP Right Cessation
- 1979-05-17 CA CA000327839A patent/CA1240325A/en not_active Expired
- 1979-05-17 JP JP6100079A patent/JPS554370A/ja active Granted
- 1979-05-17 FR FR7912635A patent/FR2434162A1/fr active Granted
- 1979-05-18 DD DD79213010A patent/DD143613A5/de unknown
-
1980
- 1980-02-01 ES ES488210A patent/ES488210A0/es active Granted
- 1980-10-28 AR AR283021A patent/AR224784A1/es active
-
1982
- 1982-11-16 YU YU02563/82A patent/YU256382A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1527048B1 (fr) | Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique | |
| EP1499589B1 (fr) | Derives de n-¬phenyl(piperidin-2-yl)methyl|benzamide, leur preparation et leur application en therapeutique | |
| US9023868B2 (en) | Deuterium-enriched lenalidomide | |
| JPH07110850B2 (ja) | 窒素含有複素環化合物のフルオロアルコキシベンジルアミノ誘導体 | |
| LU79761A1 (fr) | Procede de preparation de nouveaux composes de phtalazine et de composition pharmaceutique les contenant | |
| JPH0739387B2 (ja) | 新規１−ベンジル−アミノアルキル−ピロリジノン化合物及びその製造方法 | |
| EP0103497A1 (fr) | Nouveaux dérivés de la xanthine, leur procédé de préparation et les compositions pharmaceutiques les renfermant | |
| LU81284A1 (fr) | Nouveaux derives de 4-amino-2-piperidino-quinazoline,leur procede de production et medicament les contenant | |
| EP0558487B1 (en) | Piperidine compounds, their preparation and use | |
| FR2493315A1 (fr) | Derive de piperazine, procede pour sa preparation et composition analgesique en contenant | |
| WO2008157658A1 (en) | Deuterium-enriched montelukast | |
| CA1095047A (fr) | Procede de preparation de nouveaux derives du 1,4- benzodioxane | |
| US20090082432A1 (en) | Deuterium-enriched ramelteon | |
| CZ217495A3 (en) | 2,3-cyclically condensed 1,4-dihydropyridines, process of their preparation, medicaments in which said substances are comprised and their use | |
| JP3280040B2 (ja) | アミノベンゼン化合物 | |
| US20120035261A1 (en) | Deuterium-enriched saxagliptin | |
| US20110212976A1 (en) | Deuterium-enriched risperidone | |
| US7956080B2 (en) | Deuterium-enriched SDX-101 | |
| WO2008157565A1 (en) | Deuterium-enriched ezetimibe | |
| US20090082383A1 (en) | Deuterium-enriched buprenorphine | |
| US20090082385A1 (en) | Deuterium-enriched desloratidine | |
| WO2008157657A1 (en) | Deuterium-enriched tenofovir | |
| EP0522914A1 (fr) | Dérivés de 2-pipéridinylpyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique | |
| LU82115A1 (fr) | Nouvelles quinazolines anti-hypertensives,leur procede de production et composition pharmaceutique les contenant | |
| EP0035925A1 (fr) | Nouveaux dérivés de la chloro-3 quinoléine, procédés pour leur préparation, et médicaments les contenant |